VICTOR SOLIS OJEDA: Open Payments
NPI 1831714930 · WAIANAE, HI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$279 in 9 payments from 5 companies in 2025. Trend: 2023 $117 · 2024 $419 · 2025 $279
Food & beverage: $279
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $109 |
| Abbott Laboratories | 1 | $96 |
| ABBVIE INC. | 1 | $33 |
| Lilly USA, LLC | 1 | $22 |
| GlaxoSmithKline, LLC. | 1 | $20 |
Products named: FREESTYLE LIBRE 3, Wegovy, UBRELVY, Ozempic, ZEPBOUND, SHINGRIX.
Industry payments across HI — which companies pay providers there.
